Rchr
J-GLOBAL ID：201801013960466180
Update date: Mar. 01, 2024
KAIRA Kyouichi
カイラ キョウイチ | KAIRA Kyouichi
Affiliation and department：
Job title：
Professor
Research theme for competitive and other funds (2)：
- 2021 - 2022 Multicenter Retrospective Study to Evaluate Docetaxel plus Ramucirumab after Combination Therapy with PD-1 Inhibitor and Chemotherapy in Advanced Non-Small Cell Lung Cancer(REACTIVE study)
- 進行肺癌における免疫療法の効果を予測するためのPETと低酸素マーカーの可能性
Papers (87)：
-
Imai H, Kaira K, Masubuchi K, Minato K. Management of Lung Cancer-Associated Malignant Pericardial Effusion with Intrapericardial Administration of Carboplatin: A Retrospective Study. Curr Oncol. 2022. 29. 1. 163-172
-
Kuba K, Inoue H, Matsumura S, Enoki Y, Kogashiwa Y, Ebihara Y, Nakahira M, Yamazaki T, Yasuda M, Kaira K, et al. A retrospective analysis of tumor infiltrating lymphocytes in head and neck squamous cell carcinoma patients treated with nivolumab. Sci Rep. 2022. 12. 1. 22557
-
Yamaguchi O, Atarashi K, Yoshimura K, Shiono A, Mouri A, Nishihara F, Miura Y, Hashimoto K, Miyamoto Y, Uga H, et al. Establishing a whole blood CD4+ T cell immunity measurement to predict response to anti-PD-1. BMC Cancer. 2022. 22. 1. 1325
-
Kagamu H, Yamasaki S, Kitano S, Yamaguchi O, Mouri A, Shiono A, Nishihara F, Miura Y, Hashimoto K, Imai H, et al. Single-Cell Analysis Reveals a CD4+ T-cell Cluster That Correlates with PD-1 Blockade Efficacy. Cancer Res. 2022. 82. 24
-
Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, et al. Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival. Thorac Cancer. 2022. 13. 19. 2776-2785
ｍore...
Lectures and oral presentations (7)：
-
Management and problem of oncologic emergency in advanced lung cancer
(第25回 アジア太平洋呼吸器学会 2021)
-
EGFR遺伝子変異陽性肺がんの EGFR-TKI治療における腫瘍内AXL発現の意義
(第61回 日本呼吸器学会 2021)
-
EGFR遺伝子変異陽性肺がんのEGFR-TKI治療における腫瘍内AXL発現の意義
(第61回 日本呼吸器学会 2021)
-
EGFR-TKI耐性肺癌におけるPD-1阻害剤投与後のEGFR-TKI再投与の効果
(第61回 日本呼吸器学会 2021)
-
Neuroendocrine tumor of the breast with pulmonary metastasis 30 years after mastectomy
(32nd Congress of the European Society of Pathology and XXXIII International Congress of the International Academy of Pathology (Virchows Archiv) 2020)
ｍore...
Awards (4)：
- 2019/11 - EJNMMI Best of Article award
- 2014/06 - 小林がん学術振興会 先駆的研究助成
- 2009/11 - 第47回日本肺癌学会優秀演題賞
- 2007/12 - 群馬大学第一内科同門会賞
Return to Previous Page
